Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Kezar Life Sciences Inc
(NQ:
KZR
)
0.9016
-0.0014 (-0.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,175,764
Open
0.9100
Bid (Size)
0.8950 (98)
Ask (Size)
0.9180 (50)
Prev. Close
0.9030
Today's Range
0.8900 - 0.9165
52wk Range
0.6746 - 3.370
Shares Outstanding
72,407,215
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
From Pennies to Fortunes: 3 Stocks Set to Make Millionaires
March 27, 2024
Discover how these stocks to make millionaires are leading in the gold, biotechnology, and application software industries.
Via
InvestorPlace
Diamonds in the Dust: 3 Penny Stocks Set to Soar 500% by 2026
March 16, 2024
Learn how these penny stocks may yield a 5X return with their lead in application software and biotechnology.
Via
InvestorPlace
Performance
YTD
-5.09%
-5.09%
1 Month
-7.00%
-7.00%
3 Month
-7.59%
-7.59%
6 Month
-23.59%
-23.59%
1 Year
-72.09%
-72.09%
More News
Read More
KZR Stock Earnings: Kezar Life Sciences Misses EPS for Q4 2023
March 14, 2024
Via
InvestorPlace
Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
March 14, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
March 08, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
Analyst Expectations for Kezar Life Sciences's Future
November 27, 2023
Via
Benzinga
Week In Review: Mabwell Sells Ex-China Rights To Rare Disease Therapy In $412 Million Deal
March 02, 2024
Via
Talk Markets
Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference
February 28, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
February 26, 2024
From
Kezar Life Sciences, Inc.
Via
Business Wire
3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond
February 25, 2024
Via
InvestorPlace
3 Penny Stocks Poised for an Unbelievable 1,000% Jump
February 02, 2024
Via
InvestorPlace
As Oversupply Deflates Lithium Bubble, IPO Market Keeps In High Spirits
January 08, 2024
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Bull Run Bonanza: Top 3 Penny Stocks Primed for Explosive Growth
December 18, 2023
Via
InvestorPlace
Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
November 13, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
November 03, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
October 23, 2023
Via
ACCESSWIRE
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
October 09, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Announces Strategic Restructuring to Prioritize Clinical-Stage Assets and Extend Financial Runway and Appoints Christopher Kirk, Ph.D. as Chief Executive Officer
October 03, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023
October 05, 2023
Via
Benzinga
Week In Review: Everest Acquires Novel Autoimmune Therapy In $132 Million Agreement
September 23, 2023
Via
Talk Markets
Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
September 21, 2023
Via
Benzinga
Kezar Life Sciences and Everest Medicines Enter into an Agreement to Develop and Commercialize Zetomipzomib for Lupus Nephritis and other Potential Indications in Greater China, South Korea and Southeast Asia
September 20, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences to Participate in Three Upcoming Investor Conferences
August 31, 2023
From
Kezar Life Sciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 22, 2023
Via
Benzinga
Top 5 Health Care Stocks That Could Blast Off This Month
August 21, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.